AcheeNL, YoungbloodL, BangsMJ, LaveryJV, et al.Considerations for the use of human participants in vector biology research: A tool for investigators and regulators. Vector Borne Zoonotic Dis, 2015; 15:89–102.
2.
AdelmanZN, PledgerD, MylesKM. Developing standard operating procedures for gene drive research in disease vector mosquitoes. Pathog Glob Health, 2017; 111:436–447.
3.
AlpheyL, BenedictM, BelliniR, ClarkGG, et al.Sterile-insect methods for control of mosquito-borne diseases: An analysis. Vector Borne Zoonotic Dis, 2010; 10:295–311.
4.
BenedictM, D'AbbsP, DobsonS, GottliebM, et al.Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive system: Recommendations of a scientific working group. Vector Borne Zoonotic Dis, 2008; 8:127–166.
5.
CongL, RanFA, CoxD, LinS, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339:819–823.
FraserMJ, SmithGE, SummersMD. Acquisition of host cell DNA sequences by baculoviruses: Relationship between host DNA insertions and FP mutants of Autographa californica and Galleria mellonella nuclear polyhedrosis viruses. J Virol, 1983; 47:287–300.
8.
GantzVM, JasinskieneN, TatarenkovaO, FazekasA, et al.Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proc Natl Acad Sci U S A, 2015; 112:E6736–E6743.
9.
HammondA, GaliziR, KyrouK, SimoniA, et al.A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotechnol, 2016; 34:78–83.
10.
HiggsS. Editorial and commentary on the guidance document for the contained field trials of engineered mosquitoes. Vector Borne Zoonotic Dis, 2008; 8:125–126.
11.
HiggsS. Alternative approaches to control dengue and chikungunya: Transgenic mosquitoes. Public Health, 2013; 24:35–42.
12.
KistlerKE, VosshallLB, MatthewsBJ. Genome engineering with CRISPR-Cas9 in the mosquito Aedes aegypti. Cell Rep, 2015; 11:51–60.
13.
KojimaK, BoothCM, SummermatterK, BennettA, et al.Risk-based reboot for global lab biosafety. Science, 2018; 360:260–262.
14.
MaY, ZhangL, HuangX. Genome modification by CRISPR/Cas9. FEBS J, 2014; 281:5186–5193.
15.
MaliP, YangL, EsveltKM, AachJ, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339:823–826.
16.
MumfordJD, LeachAW, BenedictMQ, FacchinelliL, et al.Maintaining quality of candidate strains of transgenic mosquitoes for studies in containment facilities in disease endemic countries. Vector Borne Zoonotic Dis, 2018; 18:31–38.
17.
National Academies of Sciences, Engineering, and Medicine. Gene Drives on the Horizon: Advancing Science, Navigating Uncertainty, and Aligning Research with Public Values. Washington, DC: The National Academies Press, 2016.
18.
QuinlanMM, BirungiJ, CoulibalyMB, DiabateA, et al.Containment studies of transgenic mosquitoes in disease endemic countries: The broad concept of facilities readiness. Vector Borne Zoonotic Dis, 2018a; 18:14–20.
19.
QuinlanMM, MutungaJM, DiabateA, NamountougouM, et al.Studies of transgenic mosquitoes in disease-endemic countries: Preparation of containment facilities. Vector Borne Zoonotic Dis, 2018b; 18:21–30.
20.
SpielmanA, PollackRJ, KiszewskiAE, Telford SRIII. Issues in public health entomology. Vector Borne Zoonotic Dis, 2001; 1:3–19.
21.
ZhangF, WenY, GuoX. CRISPR/Cas9 for genome editing: Progress, implications and challenges. Hum Mol Genet, 2014; 23:R40–R46.